Biotinoyl tripeptide-1
Cosmetic ingredientCosmetic biotinylated peptide
Also known as: Procapil, biotinoyl-GHK, Biotin-GHK, Biotin Tripeptide-1(acetate), Bio-GHK, Biotinoyl GHK, Biotinoyl-Tripeptide-1, BiotinoylTripeptide-1?
Early evidence, mostly unproven in humans
- Regulatory standing. Cosmetic ingredient, not regulated as a drug
- Limited human data. Some human data exists, not conclusive
- Registered human trials. 2 registered studies on ClinicalTrials.gov
- 1 cited source. Includes primary / regulatory sources
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
Biotinoyl tripeptide-1 is a lab-made peptide in which biotin is attached to the tripeptide glycine-histidine-lysine (GHK). It is used as a cosmetic ingredient in hair and scalp products, sometimes as part of the blend marketed as Procapil. It is thought to act on hair follicle cells by supporting anchoring of the hair to the follicle, but this mechanism comes mainly from manufacturer and lab data.
What the evidence shows
It is not FDA-approved and is sold only as a cosmetic ingredient. Two registered human trials exist with no listed phase and no indexed published papers, so any effect on hair loss in people is not established.
Key facts
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Sources
- PubChem compound record (CID 11534242)
- Registered trials on ClinicalTrials.gov
- Published papers on Europe PMC
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.